Machine Perfusion of Porcine Livers with Oxygen-Carrying Solution Results in Reprogramming of Dynamic Inflammation Networks by David Sadowsky et al.
fphar-07-00413 November 3, 2016 Time: 11:27 # 1
ORIGINAL RESEARCH
published: 04 November 2016
doi: 10.3389/fphar.2016.00413
Edited by:
Craig J. Thalhauser,
Bristol Myers Squibb, USA
Reviewed by:
Christos Argyropoulos,
University of New Mexico, USA
Hesham Abdeldayem,
National Liver Institute, Egypt
Kotambail Venkatesha Udupa,
University College Dublin, Ireland
*Correspondence:
Yoram Vodovotz
vodovotzy@upmc.edu
†These authors have contributed
equally to this work (co-senior
authors).
Specialty section:
This article was submitted to
Experimental Pharmacology and Drug
Discovery,
a section of the journal
Frontiers in Pharmacology
Received: 25 June 2016
Accepted: 18 October 2016
Published: 04 November 2016
Citation:
Sadowsky D, Zamora R, Barclay D,
Yin J, Fontes P and Vodovotz Y
(2016) Machine Perfusion of Porcine
Livers with Oxygen-Carrying Solution
Results in Reprogramming
of Dynamic Inflammation Networks.
Front. Pharmacol. 7:413.
doi: 10.3389/fphar.2016.00413
Machine Perfusion of Porcine Livers
with Oxygen-Carrying Solution
Results in Reprogramming of
Dynamic Inflammation Networks
David Sadowsky1, Ruben Zamora1,2, Derek Barclay1, Jinling Yin1, Paulo Fontes1,2,3† and
Yoram Vodovotz1,2*†
1 Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA, 2 McGowan Institute for Regenerative Medicine,
University of Pittsburgh, Pittsburgh, PA, USA, 3 Department of Surgery, Thomas E. Starzl Transplantation Institute,
Pittsburgh, PA, USA
Background: Ex vivo machine perfusion (MP) can better preserve organs for
transplantation. We have recently reported on the first application of an MP protocol in
which liver allografts were fully oxygenated, under dual pressures and subnormothermic
conditions, with a new hemoglobin-based oxygen carrier (HBOC) solution specifically
developed for ex vivo utilization. In those studies, MP improved organ function post-
operatively and reduced inflammation in porcine livers. Herein, we sought to refine our
knowledge regarding the impact of MP by defining dynamic networks of inflammation in
both tissue and perfusate.
Methods: Porcine liver allografts were preserved either with MP (n = 6) or with
cold static preservation (CSP; n = 6), then transplanted orthotopically after 9 h of
preservation. Fourteen inflammatory mediators were measured in both tissue and
perfusate during liver preservation at multiple time points, and analyzed using Dynamic
Bayesian Network (DyBN) inference to define feedback interactions, as well as Dynamic
Network Analysis (DyNA) to define the time-dependent development of inflammation
networks.
Results: Network analyses of tissue and perfusate suggested an NLRP3
inflammasome-regulated response in both treatment groups, driven by the pro-
inflammatory cytokine interleukin (IL)-18 and the anti-inflammatory mediator IL-1
receptor antagonist (IL-1RA). Both DyBN and DyNA suggested a reduced role of IL-
18 and increased role of IL-1RA with MP, along with increased liver damage with CSP.
DyNA also suggested divergent progression of responses over the 9 h preservation time,
with CSP leading to a stable pattern of IL-18-induced liver damage and MP leading to
a resolution of the pro-inflammatory response. These results were consistent with prior
clinical, biochemical, and histological findings after liver transplantation.
Conclusion: Our results suggest that analysis of dynamic inflammation networks in the
setting of liver preservation may identify novel diagnostic and therapeutic modalities.
Keywords: modeling, transplant, porcine, inflammation, reprogramming, networks
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INTRODUCTION
Organ availability for liver transplantation continues to fall
well short of demand. During 2012 in the United States, 6,256
transplants were performed compared with 10,143 candidates
added to the waiting list. A troubling trend contributing to
this imbalance is the increasing organ discard rate, which has
risen from 15% in 2004 to 21% in 2010. Organ discard has
been associated with older donor age, higher body mass index,
and diabetes, all of which have been increasing in the donor
population (Orman et al., 2013).
One strategy to reduce the discard rate is to improve organ
preservation from the current standard method of CSP, where
organs are stored in hypothermic (4◦C) and anoxic conditions.
A variety of applications of ex vivo MP as a means to better
preserve organs have been investigated recently with promising
results (Monbaliu and Brassil, 2010). MP is a technology
developed to provide better conditions for organ preservation
before transplantation (Lindbergh et al., 1966). MP devices are
built primarily as closed perfusion systems capable of pumping
preservation solutions (perfusate) through the organ circulation
under sterile conditions and controlled temperatures (Monbaliu
and Brassil, 2010). MP devices were initially developed for
kidney preservation, with research focused primarily on flow and
pulsatile pressures under hypothermic (4◦C) conditions. These
devices used standard, non-oxygenated preservation solutions,
such as UW, for perfusate (Daemen et al., 1997). The first device
approved in the US by the FDA for kidney preservation in
2009 perfused the organs at 4◦C without oxygenation (Moers
et al., 2009). Unfortunately, this generation of devices had
limited impact in both graft and patient survival 5 years after
transplantation and became obsolete (De Deken et al., 2016).
Subsequent MP devices were developed that instead preserved
organs under normothermic (37◦C) conditions and used oxygen
carrier solutions for perfusate. Recently, two new MP devices
have been approved for lung preservation at 37◦C using purged
red blood cells for the primary oxygen carrier component (Cypel
et al., 2009).
Machine perfusion for liver preservation was initially
conceived similarly to the aforementioned kidney devices using
hypothermic preservation, and the results were analogous
regarding the lack of a major benefit from this technique
(Guarrera et al., 2010). Additional clinical developments with MP
for liver preservation have utilized a short period of hypothermic
(4◦C) oxygenation (HOPE), with results exceeding initial
expectations (Dutkowski et al., 2014). Most recently, a clinical
trial of an MP system using fully oxygenated, normothermic red
blood cells has been completed with somewhat disappointing
results (Bral et al., 2016). We recently added to this growing
Abbreviation: ALT, alanine transaminase; AST, aspartate transaminase; CSP, cold
static preservation; DyBN, dynamic Bayesian Network inference; DyNA, dynamic
network analysis; GM-CSF, granulocyte macrophage colony-stimulating factor;
HA, hepatic artery; HBOC, hemoglobin-based oxygen carrier; IFN, interferon; IL,
interleukin; IR, ischemia/reperfusion; KC, Kupffer cell; MP, machine perfusion;
NKT, natural killer T-cell; PaO2, arterial oxygen pressure; PV, portal vein;
SaO2, arterial oxygen saturation; TNF, tumor necrosis factor; UW, University of
Wisconsin solution.
body of work with the first application of a MP protocol
in which liver allografts were fully oxygenated, under dual
pressures and subnormothermic conditions (21◦C), with a new
HBOC solution specifically developed for ex vivo utilization.
A comprehensive study of transcriptomic, metabolomic,
histologic, and inflammatory responses highlighted multiple
benefits of our MP protocol when compared to CSP (Fontes
et al., 2015).
The inflammatory mediator analyses in our study suggested
that perfusion with MP results in decreased tissue levels
of IFN-α, IFN-γ, TNF-α, IL-1β, IL-4 and IL-12/IL23 (p40)
compared to CSP, suggesting a broad-based down-regulation of
the pro-inflammatory response (Fontes et al., 2015). However,
inflammation is much more than single mediators. Inflammation
comprises complex dynamic networks that feature hundreds
of mediators from differing cell types, variability over time,
and interrelation of mediators due to feedback mechanisms.
Compounding this complexity is frequent pleiotropy and
redundancy, as well as the multiscale aspect inherent in a system
that affects multiple tissues and organs. We and others have been
able to gain insights into these networks using quasi-mechanistic
data-driven computational modeling based on tools such as
principal component analysis and various forms of DyNA (Mi
et al., 2011; Azhar et al., 2013; Vodovotz and Billiar, 2013; Ziraldo
et al., 2013; Emr et al., 2014; Zaaqoq et al., 2014; Almahmoud
et al., 2015; Sadowsky et al., 2015). In the work presented herein,
we use Dynamic Bayesian Network (DyBN) inference and DyNA
to further clarify and compare the patterns of inflammation
resulting from both CSP and MP, in an effort to better understand
the mechanisms by which our protocol exerts its effects.
MATERIALS AND METHODS
The experiments generating the data for this mathematical
analysis were previously published (Fontes et al., 2015). Thus,
the comprehensive and specific description of procedural
methods can be found in the original publication. An overview
of these methods has been restated below as reference for
the computational analysis performed in the present study.
The protocol was approved by the University of Pittsburgh
Institutional Animal Care and Use Committee (IACUC, protocol
number 13102322) and conducted according to the NIH Guide
for the Care and Use of Laboratory Animals.
Surgical Procedures
Allografts from two groups of six animals (Landrace pigs, 60 kg)
were recovered under general anesthesia, procured according
to standard surgical techniques, and flushed simultaneously
through the HA and PV with 5 L UW at 4◦C immediately after
cross clamp and exsanguination.
The CSP allografts were preserved under standard
hypothermic and static conditions with continuous temperature
monitoring.
An MP system (Liver AssistCE) from Organ Assist
(Groningen, the Netherlands) was utilized. MP livers had
both arterial and PV cannulas inserted before placement into
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the device, with cannulation taking 15 min. The perfusate
was oxygenated continuously (FiO2 = 60% @ 800 mL/min,
O2 delivery = 14.1 mL O2/min) through microporous
oxygenators. MP was conducted under low flows (PV
flow = 259 ± 40 mL/min; HA flow = 91 ± 36 mL/min), stable
temperature (21◦C) and low pressures (PV = 3.5 ± 0.5 mmHg,
HA= 18± 2 mmHg). Pressures were established and maintained
in a stable and narrow range (Supplementary Figure S1). These
values were selected after extensive prior titration studies, and
are lower than physiologic values in order to avoid endothelial
cell damage within organ vasculature.
A new, cell-free HBOC solution was developed by combining
a stable, second-generation, bovine-derived hemoglobin
compound (Jahr et al., 2008) (HemopureTM; OPK Biotech,
Cambridge, MA, USA) with a hetastarch-based colloid (Belzer
Machine Perfusion Solution, Preservation Solutions, Inc.,
Elkhorn, WI, USA). The HBOC component had an initial
hemoglobin concentration of 13 g/dL, a half-life of 20 h and
a clearance of 0.12 L/h. This solution can bind up to 1.36 mL
O2 per gram of hemoglobin when fully saturated (Jahr et al.,
2007; McNeil et al., 2011). The combined solution (Vir1;
VirTech Bio Inc., Beverly, MA, USA) had a final hemoglobin
concentration of 3.5g/dL and the following characteristics:
pH 7.62, osmolality = 296 mOsm/kg, colloid osmostic
pressure = 59.1 mmHg, Na+ = 105 mmol/L, K+ = 17.3
mmol/L, Cl− = 36 mmol/L and Ca++ = 0.24 mmol/L.
Measurements
Samples of perfusate and tissue were taken at four time points:
a baseline with normal blood flow was taken immediately before
cross clamp application in the donor, and after 3, 6, and 9 h of
preservation, either by CSP or MP as detailed above.
Tissue and perfusate assays of IFN-α, IFN-γ, IL-10, IL-12/IL-
23 p40, IL-1β, IL-4, IL-6, IL-8 and TNF-α were carried out using
a LuminexTM beadset from Affymetrix (Santa Clara, CA, USA).
GM-CSF, IL- 1α, IL-1RA, IL-2 and IL-18 were measured using a
LuminexTM beadset from Millipore (Merck KGaA, Darmsdadt,
Germany) (Barclay et al., 2008). Perfusate samples were also
assessed for AST and ALT. Tissue samples were normalized by
protein content to account for experimental variability in cell
number and protein concentration among individual samples.
Perfusate assays were unable to be obtained for one pig in the
CSP group, which was excluded from the subsequent perfusate
analyses for that group.
Dynamic Bayesian Network Inference
Given time-series data, DyBN inference is a method for
suggesting causal relationships among variables based on
probabilistic measure. In a DyBN, variables are shown as nodes
and the interconnections are shown as edges. Unlike standard
correlative approaches, DyBNs consider the joint distribution
of the entire data set when making inferences about the
dependencies among variables or nodes in the network. This
analysis was carried out in MATLAB (The MathWorks, Inc,
Natick, MA, USA), using an algorithm adapted from Grzegorczyk
and Husmeier (Grzegorczyk and Husmeier, 2011) and revised
by our group (Mi et al., 2011; Azhar et al., 2013; Ziraldo
et al., 2013; Emr et al., 2014; Namas et al., 2014; Zaaqoq et al.,
2014; Almahmoud et al., 2015; Sadowsky et al., 2015). The
inference procedure was run individually for each pig, and
the marginal edge probabilities averaged across all runs. The
thickness of edges was weighted by this number, and only edges
with an averaged marginal edge probability greater than 0.5
were included in the final consensus network for each condition.
Exact edge probabilities for resultant networks are included in
Supplementary Table S1. We note that this algorithm is unable
to determine directly the positive or negative nature of edges
connecting the nodes, as well as whether edges represent a linear
or other type of relationship.
Dynamic Network Analysis
After using DyBN to outline the patterns and relationships
prevalent throughout the entire experimental course, DyNA was
performed to track the progression of inflammatory networks
during the process of organ preservation. The mathematical
formation of this method is essentially to calculate the correlation
among the variables by which we can examine their dependence,
and we have applied it in the past to the study of inflammatory
networks in murine and human data (Mi et al., 2011; Ziraldo
et al., 2013; Namas et al., 2014). Networks were created in
adjacent 3-h intervals (Baseline – 3 h, 3 – 6 h, 6 – 9 h).
In order to be included in a network, a given mediator had
to be statistically significantly different from its baseline value
(p < 0.05 by Student’s t-test). Unlike DyBN, DyNA allows for
the discrimination of positive and negative connections between
variables. Positive edges in the network were created if the value
of the correlation coefficient between two nodes (inflammatory
mediators) was greater than or equal to a threshold of 0.7
(p < 0.05), and negative edges were created if the coefficient
was less than or equal to −0.7 (p < 0.05). All work was carried
out using MATLAB R© and Inkscape1 software. For the network
density calculation we utilized the following formula (a minor
revision of that reported by Assenov et al. (2008)):
Total number of edges ∗ Number of total nodes
Maximum possible edges among total nodes
RESULTS
For each preservation method, we first sought to identify
the dynamic inflammatory network characterizing the entire
experimental time course, as well as identifying potential
central nodes (i.e., nodes that exhibit self-feedback and that
therefore may be central regulators of the dynamic inflammatory
response), by using DyBN on data from all time points. DyBN
depicts the entire time progression of a given network as a
single graph. Then, using DyNA, we sought to define the
time-dependent progression of these inflammation networks
in a more granular fashion over the period of preservation,
allowing for a higher resolution portrayal of the time course of
inflammation as well as highlighting both positive and negative
regulatory interactions. The tradeoff in this analysis is that DyNA,
1http://inkscape.org
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FIGURE 1 | Tissue sample DyBNs suggest conserved network structure with central nodes IL-18 and IL-1RA, but decreased pro-inflammatory
response with MP. CSP, cold static preservation (n = 6). Organs were preserved at standard hypothermic and anoxic conditions. MP, machine perfusion (n = 6).
Organs were fully oxygenated under dual pressures under subnormothermic conditions with a new hemoglobin-based oxygen carrier solution specifically developed
for ex vivo utilization. Multiple inflammatory mediators were interrelated using DyBN inference. While the overall network structure is maintained, MP features fewer
edges from the pro-inflammatory IL-18 than CSP.
unlike DyBN inference, does not define self-feedback structures.
Analyses were completed on both tissue and perfusate data to
allow for multiple representations of the liver.
We hypothesized that central nodes (which we define as
DyBN network nodes that exhibit self-feedback and that connect
to other nodes that do not have this property) represent key
inflammation control mechanisms. Our analyses of tissue data
(Figure 1) suggest an overall response coordinated by the pro-
inflammatory cytokine IL-18 and the anti-inflammatory IL-
1 receptor antagonist (IL-1RA). Of note, treatment with MP
is associated with an appreciably diminished centrality of IL-
18 as compared to CSP, with IL-18 having only 4 external
connections (not to itself or to IL-1RA) in the MP network
compared with 8 outputs in the CSP network. Our analyses
of perfusate data (Figure 2) also infer networks driven by
IL-18 and IL-1RA, with additional central nodes including
AST in the CSP group vs. AST and ALT in the MP group.
Again, in these analyses we infer a reduced centrality of
IL-18 in the MP group as compared to the CSP group,
with one fewer output and no self-feedback in the MP
network.
The liver injury marker AST is also less central in the MP
perfusate network, similar to what we infer for IL-18, with
only 2 non-self outputs compared to 5 in CSP. Additionally,
the CSP network includes bidirectional edges between AST and
both IL-18 and IL-1RA, while the MP network only contains a
unidirectional edge to AST from IL-18 and no edges between AST
and IL-1RA. Another noteworthy difference is the output edge of
AST to IL-6 in the CSP network only, with IL-6 not present at all
in the MP network.
Tissue DyBNs show more connections from IL-1RA to pro-
inflammatory mediators in MP networks than CSP. For example,
an output from IL-1RA to the major pro-inflammatory mediator
IL-6 only exists in the MP network. As noted in “Materials
and Methods,” edges between nodes in DyBNs may be of a
positive or negative nature. Given the known role of IL-1β as an
inducer of IL-6, we hypothesize that edges from IL-1RA to other
inflammatory mediators represent a negative effect, something
that is not observed in CSP. Similarly, other pro-inflammatory
mediators that appear in both tissue networks (IL-8, TNF-α, and
GM-CSF) are only connected to IL-1RA in MP, but connect to
both IL-1RA and IL-18 in CSP.
DyNA networks were then constructed for all time intervals,
with variables and edges included in each network (Figure 3).
Tissue networks consistently include more variables and
connections than perfusate. Tissue networks also feature
numerous negative (anticorrelated) edges, which we interpret
as suppressive interactions. Within the tissue analyses, MP
networks contain more negative edges and feature the earlier
appearance of negative edges than CSP. Network complexity
scores (Figure 4) are consistently higher in tissue networks than
perfusate. For both sample types, the initial CSP network is the
most complex, with CSP network complexity decreasing over
time. MP networks, which for both sample types start with
lower complexity than CSP, remain relatively static in complexity
throughout the preservation period.
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IL-18, IL-1β, IL-1RA and IFN-γ are among the variables
included in every tissue DyNA network (Figure 5). In the
CSP analysis, a complex network for the initial timeframe is
followed by two networks in which a majority of variables
only have two edges. Of note, these latter networks are almost
identical, with the only differences being two additional edges
connecting IL-8 with IL-12/23 (p40) and IFN-α, along with the
absence of TNF-α in the final network. Unlike CSP, the MP
networks continue to fluctuate throughout the experimental time
course, suggesting the possibility that MP actively and repeatedly
counters inflammatory signaling. A similar pattern is seen the
perfusate DyNA networks (Figure 6). The CSP analysis again
features an initially complex network followed by two simpler
and similar networks. Likewise, the MP analysis again features
fluctuating networks throughout the preservation period.
In the early time interval of DyNA networks inferred in
perfusate obtained from CSP organs (Figure 6A), IL-18 is
connected to multiple pro-inflammatory mediators (IL-1α, IL-1β
and IL-8, which all then connect to IL-6). IL-1RA is not included
in this network. In MP organs during this interval (Figure 6B),
however, IL-1RA is included and connects to IL-18, which has no
connections to other inflammatory mediators.
Subsequent perfusate DyNA networks suggest that the
responses in CSP and MP organs continue to diverge as time
spent under preservation progresses. By 3–6 h in the CSP group,
IL-18 has developed direct connections to the liver damage
markers AST and ALT, and these connections continue in the 6–
9 h interval (Figures 6C,E). IL-1RA never appears in the CSP
networks. The 3–6 h interval in MP (Figure 6D) continues to
show the connection between IL-1RA and IL-18 seen initially,
but has lost the connection between IL-18 and AST from the first
interval. By 6–9 h (Figure 6F), IL-18, IL-1RA, and AST/ALT are
no longer present in the network (meaning they are no longer
significantly different from their baseline values).
Taken together, we interpret the CSP and MP results to suggest
that IL-18 (or pathways responsible for the generation of IL-18,
such as the NLRP3 inflammasome; Elliott and Sutterwala, 2015)
drives multiple secondary inflammatory mechanisms triggered
by IR insult that subsequently or consequently lead to liver
injury. In CSP, this process is persistent and sometimes (67%
mortality) irreversible, whereas in MP this process is attenuated
and eventually blocked by what we interpret to be an IL-1RA
driven anti-inflammatory response. In perfusate, we observed
significantly higher levels of IL-1RA with MP vs. CSP (Table 1).
Notably, these inferences of a central role for IL-18 and a
diminished role for IL-18 in MP vs. CSP livers occur despite a lack
of statistically significant differences in the levels of IL-18 between
protocols for either sample type; likewise, there is no statistically
significant difference in the tissue levels of IL-1RA analyzed in
our original work (Table 1).
DISCUSSION
The preservation of organs undergoing transplantation has
recently become a focus of research seeking to improve
organ availability and clinical outcomes (Ali et al., 2015). Our
FIGURE 2 | Perfusate sample DyBNs suggest conserved network
structure with central nodes IL-18 and IL-1RA, but decreased
pro-inflammatory response and liver damage with MP. CSP, cold static
preservation (n = 5). Organs were preserved at standard hypothermic and
anoxic conditions. MP, machine perfusion (n = 6). Organs were fully
oxygenated under dual pressures under subnormothermic conditions with a
new hemoglobin-based oxygen carrier solution specifically developed for ex
vivo utilization. Multiple inflammatory mediators and liver damage markers AST
and ALT were interrelated using DyBN inference. While the overall network
structure is maintained, MP features fewer edges from the pro-inflammatory
IL-18 than CSP, including a loss of both IL-18 self-feedback and an edge from
IL-18 to major pro-inflammatory mediator IL-6. The centrality of liver damage
markers AST and ALT is also decreased with MP, as seen most notably by the
loss of bidirectional edges between AST and both IL-18 and IL-1RA.
prior work demonstrated the suppression of numerous pro-
inflammatory mediators by MP compared to CSP, implying
a decreased inflammatory response associated with improved
liver preservation. These measurements were accompanied by
transcriptomic, metabolomic, histologic and clinical results
largely supporting a conclusion of improved organ and systemic
function associated with MP (Fontes et al., 2015). In the present
study, we hypothesized that different, dynamic networks of
inflammation characterize – and likely play a key role in – the
differential impact of MP vs. CSP on the preservation process.
Whereas traditional statistical approaches are able to identify
and determine significant differences in levels of various
variables, DyBN inference and DyNA allow us to better
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FIGURE 3 | Tissue sample DyNA networks contain more variables, total and negative edges than perfusate. CSP, cold static preservation (n = 6, tissue;
n = 5, perfusate). Organs were preserved at standard hypothermic and anoxic conditions. MP, machine perfusion (n = 6, tissue; n = 6, perfusate). Organs were fully
oxygenated under dual pressures under subnormothermic conditions with a new hemoglobin-based oxygen carrier solution specifically developed for ex vivo
utilization. DyNA networks were then constructed for all timeframes, with variables and edges included in each network. Tissue networks consistently include more
variables and connections than perfusate. Tissue networks also feature numerous negative (red, anticorrelated) edges. Within the tissue analyses, MP networks
contain more negative edges and feature the earlier appearance of negative edges than CSP.
FIGURE 4 | Network complexity DyNA. CSP, cold static preservation (n = 6, tissue; n = 5, perfusate). Organs were preserved at standard hypothermic and
anoxic conditions. MP, machine perfusion (n = 6, tissue; n = 6, perfusate). Organs were fully oxygenated under dual pressures under subnormothermic conditions
with a new hemoglobin-based oxygen carrier solution specifically developed for ex vivo utilization. Network complexity scores are consistently higher in tissue
networks than perfusate. For both sample types, the initial CSP network is the most complex, with CSP network complexity decreasing over time. MP networks,
which for both sample types start with lower complexity than CSP, remain relatively static in complexity throughout the preservation period.
understand subtle relationships among variables (beyond the
broad types of changes that are defined by traditional statistical
analyses). Defining dynamic networks also allows us to form
novel hypotheses regarding key control mechanisms. We have
previously demonstrated the use of DyBN inference in assessing
systemic inflammatory networks in human liver transplant
patients (Azhar et al., 2013) and on porcine data in studying
responses to acute trauma and sepsis, including a model
incorporating multiple sample types representative of discrete
bodily compartments (Emr et al., 2014; Sadowsky et al., 2015).
Our work with DyNA demonstrated novel features associated
with both experimental and clinical trauma/hemorrhage (Mi
et al., 2011; Ziraldo et al., 2013; Namas et al., 2014), as well
as defining networks of inflammatory mediators in murine
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FIGURE 5 | Tissue sample DyNA networks suggest different network stability between preservation methods. CSP, cold static preservation (n = 6).
Organs were preserved at standard hypothermic and anoxic conditions. MP, machine perfusion (n = 6). Organs were fully oxygenated under dual pressures under
subnormothermic conditions with a new hemoglobin-based oxygen carrier solution specifically developed for ex vivo utilization. IL-18, IL-1β, IL-1RA and IFN-γ are
among the variables included in every tissue DyNA network. In the CSP analysis a complex initial network is followed by two networks in which a majority of variables
only have two edges and whose structures are almost identical. Unlike CSP, the MP networks continue to fluctuate throughout the experimental time course.
hepatocytes exposed to hypoxia (Ziraldo et al., 2013). We have
now applied these methods to the study of liver preservation, in
the context of tissue and perfusate samples from livers subjected
to CSP vs. MP.
We found similar results in both liver tissue and perfusate
samples. Our studies suggest that the resultant network structures
from DyBN inference, which encompass all data from the
complete duration of the experiment, are preserved across sample
types. This similarity is to be expected given the related nature of
liver tissue and perfusate, shows that perfusate (representing the
intravascular and extracellular space) can be used as reflection
of processes occurring in tissue, and serves as an internal
demonstration of the consistency and reproducibility of our
methods and results. Our results suggest that perfusate could be
analyzed in serial fashion, pointing to practical applications of
our study: perfusate is also more readily obtainable than tissue,
and unlike tissue the process of sampling it does not induce
injury. Our results thus suggest that defining dynamic networks
of inflammation and organ (patho)physiology based on data
obtained from the perfusate can serve as a potential diagnostic
strategy.
Our analytical strategy may also help elucidate novel
mechanistic interactions. In the present study, the inferences
obtained by our algorithms correlate well with both known
and novel inflammatory and hepatic pathophysiology centered
on the inflammasome pathway (Hoque et al., 2013). IL-18 is a
product of the NLRP3 inflammasome, a multi-enzyme complex
that also leads to the production of mature IL-1β (Elliott and
Sutterwala, 2015), and is a potent pro-inflammatory cytokine that
exerts its effects early in inflammatory pathways (Tsutsui et al.,
2000; Gracie et al., 2003). While not specific to the liver, IL-18
expression is known to be enhanced in acute hepatic diseases such
as fulminant hepatic failure and acute hepatitis (Yumoto et al.,
2002). The NLRP3 inflammasome is expressed in the liver by
KC, including in hepatic I/R injury (Kim et al., 2015). KC are
the key cell type in early hepatic injury, and the key mediator
in this process is IFN-γ (Weigand et al., 2012). In response to
hepatic insult, IL-1β and IL-18 are released by KC via NLRP3.
IL-1β, in addition to its downstream pro-inflammatory effects,
recruits CD4+ T cells to the liver, and these CD4+ T cells in
turn release IFN-γ (Weigand et al., 2012). IL-18, meanwhile,
directly up-regulates Natural Killer-T cells (NKT), which are
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FIGURE 6 | Perfusate sample DyNA networks suggest divergent responses to preservation methods. CSP, cold static preservation (n = 5). Organs were
preserved at standard hypothermic and anoxic conditions. MP, machine perfusion (n = 6). Organs were fully oxygenated under dual pressures under
subnormothermic conditions with a new hemoglobin-based oxygen carrier solution specifically developed for ex vivo utilization. CSP networks show initial inclusion
and interrelation of numerous pro-inflammatory mediators, including IL-18, and progress to stable connections between IL-18 and both AST and ALT, suggesting
continual inflammation-driven liver damage. Anti-inflammatory IL-1RA never appears. MP networks show a restrained initial network, with IL-18 connected to IL-1RA
and damage marker AST, but not to pro-inflammatory mediators. IL-18 then loses its connection to AST and by the final time period IL-18, IL-1RA, AST and ALT are
not included, suggesting control and resolution of inflammation with minimal liver damage.
major producers of IFN-γ (Okamura et al., 1998; Tsutsui et al.,
2000). IL-18 also acts synergistically with IL-12 to stimulate IFN-
γ production in CD4+ T cells, having little effect alone on this
particular cell type (Tsutsui et al., 2000). IFN-γ further damages
hepatocytes and stimulates KC, creating a positive feedback loop
that drives this process and makes IFN-γ a key determinant
in the overall strength of response (Abu-Amara et al., 2010;
Weigand et al., 2012). The NLRP3 inflammasome is expressed
elsewhere in the liver as well (including sinusoidal endothelial
cells, portal fibroblasts, stellate cells and hepatocytes), though
levels are highest in KC (Boaru et al., 2012).
The primary negative regulator of the NLRP3-driven
inflammatory response is IL-1RA, which prevents the binding
of IL-1β to its receptor and therefore blocks it from exerting its
effects. Hepatocytes are the primary source of IL-1RA during
sterile inflammation (Lamacchia et al., 2010), and this protein
is an acute phase reactant (Gabay et al., 1997) that responds to
IL-1β (Lamacchia et al., 2010), including in humans (Bargetzi
et al., 1993). Indeed, treatment with IL-1RA reduces hepatic
inflammation in an in vitro model of hyperactive NLRP3 (Wree
et al., 2014).
Much of this well-described response is captured in our
results. The early and central role for the NLRP3 inflammasome
is represented by the centrality and upstream nature of IL-18 and
IL-1RA, the latter of which, as noted in the Results, we believe
is directly reflective in our networks of the function of IL-1β.
The output of IFN-γ in response to NLRP3 activation is seen
as well: two of four DyBNs contain an edge from IL-18 to IFN-
γ, thus inferring correctly the major downstream effect of IL-18
in this system. Additionally, all DyBNs except one capture the
connection between IL-18 and IL-12/IL-23 (p40). Interestingly,
the only DyBN missing IL-18 self-feedback is also the only one
that lacks an edge between IL-18 and IL-12/IL-23 (p40), further
reinforcing the possible synergy between these two cytokines in
the production of IFN-γ. Finally, a role for liver damage (as
represented by AST and ALT) in driving further inflammation is
also implied by DyBN inference: AST self-feedback in perfusate
networks. The direct connection of IL-18 to this damage is
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suggested by the inclusion of both an input and output edge
between IL-18 and at least one damage marker in perfusate
DyBNs, and by edges between IL-18 and AST/ALT in multiple
CSP perfusate DyNA networks.
Our results, in addition to capturing known responses, may
also help to explain the mechanisms by which MP leads to
improved outcomes. As described above and summarized in
Figure 7, levels of IFN-γ, and by extension the strength of
the IFN-γ-driven positive feedback loop of hepatic damage, are
connected in three pathways to the early, NLRP3-driven hepatic
response to insult. One of these pathways can be downregulated
by IL-1RA (C), one can be upregulated by IL-18 (A), and one can
be both downregulated by IL-1RA and upregulated by IL-18 (B).
Thus, the relative balance of these two mediators may control
TABLE 1 | Perfusate IL-1RA levels are significantly lower with CSP vs. MP.
Sample Type Cytokine Protocol Mean ± SEM, pg/mL P Value
Perfusate IL-18 CSP 738 ± 111 0.299
MP 932 ± 155
IL-1RA CSP 230 ± 34 0.005∗
MP 7317 ± 1953
Tissue IL-18 CSP 1600 ± 153 0.839
MP 1544 ± 243
IL-1RA CSP 2478 ± 270 0.539
MP 2733 ± 324
CSP, cold static preservation (Perfusate, n = 5; Tissue, n = 6). Organs were
preserved at standard hypothermic and anoxic conditions. MP, machine perfusion
(Perfusate, n = 6; Tissue, n = 6). Organs were fully oxygenated under dual
pressures under subnormothermic conditions with a new hemoglobin-based
oxygen carrier solution specifically developed for ex vivo utilization. Two-way
ANOVA was performed on cytokine levels for 3, 6, and 9 h of preservation. There
is no statistically significant difference in the tissue levels of either cytokine analyzed
in our original work. ∗statistically significant.
the level of response. DyBN inference suggests a decreased
IL-18-driven response, increased IL-1RA-driven response, and
decreased liver damage with MP compared to CSP.
DyNA results for both tissue and perfusate analyses show MP
networks that fluctuate in complexity and pattern throughout
the preservation period, while CSP networks stay relatively
constant after 3 h. We hypothesize that this difference between
protocols reflects an early response in CSP organs that generates
enough positive feedback to “lock” the organ into a pattern
of self-sustaining inflammatory damage, while MP provides
sufficient metabolic support to reduce the positive feedback
loop of (IL-18-driven) inflammation→ damage (AST/ALT)→
inflammation, presumably through mechanisms which decrease
NLRP3 activation and/or stimulate the release of IL-1RA.
These results were all aligned with previously described clinical
and laboratorial findings related to hepatic function during
preservation and after liver allograft reperfusion (Fontes et al.,
2015).
This work highlights the value that may be added by
augmenting conventional statistical analyses with data-driven
modeling techniques. Whereas our original results point to
an overall decrease in inflammation with MP treatment
based on statistical analysis of a collection of individual pro-
inflammatory mediators (Fontes et al., 2015), our current work
serves to elucidate the interconnected and dynamic nature of
this alteration. More specifically, our current work points to
differential regulation of the inflammatory response by IL-18
and IL-1RA. Importantly, the tissue levels of these mediators in
our original analysis were not statistically significantly different
between the CSP and MP groups. Rather, these mediators are
inferred to act upstream of those significantly altered mediators,
and earlier in time, creating an alternative and potentially
more worthwhile direction for future experimentation. We
suggest that the expanded use of computational modeling, in
FIGURE 7 | Hepatic response to insult regulated by IL-18, IL-1RA. Levels of IFN-γ, and by extension the strength of the IFN-γ-driven positive feedback loop of
hepatic damage, are connected in three pathways to the early, NLRP3-driven hepatic response to insult. One of these pathways can be downregulated by IL-1RA
(C), one can be upregulated by IL-18 (A), and one can be both downregulated by IL-1RA and upregulated by IL-18 (B). Thus, the relative balance of these two
mediators may control the level of response.
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iteration with traditional experimentation and analysis, may be
a means to accelerate and add efficiency to the study of complex
inflammatory pathways.
In addition to expanding the methods available to scientists
researching inflammation, our work also serves as a framework
for future studies in organ preservation, which could lead into
a rather important predictive tool for IR lesions sustained
before, during, and after organ preservation. Because of the
aforementioned comprehensive study of the same organs and
data used herein, our current results can be interpreted not just
as an isolated comparison of two preservation protocols, but
more broadly as prototype networks representing well- vs. poorly
preserved organs. With these results as a baseline, networks could
be constructed using limited organs and resources, in order to
screen new preservation protocols and to identify therapeutic
or diagnostic candidates worthy of more extensive study. In the
future, as research on discarded organs expands and preservation
methods are improved, modeling may be used to characterize
different disease states and track attempts to improve organ
function in an extracorporeal environment.
CONCLUSION
We suggest that the use of dynamic network analyses on
inflammation biomarker data in the setting of liver preservation
both complements our prior results and substantiates our
understanding of the cellular and sub-cellular mechanisms
by which MP exerts its observed beneficial effects. These
computational tools may serve as a framework for discovering
novel diagnostic or therapeutic modalities for enhanced liver
preservation.
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